EUVIMEDEUVIMED entdecken
BeobachtungsstudieOpen Access · CC BY 4.0

Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies

Hyung Duk Kim iD, Hyunjoo Bae iD, Sojeong Yun, Hanbi Lee iD, Sang Hun Eum, Chul Woo Yang iD, Eun-Jee Oh iD, Byung Ha Chung iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241814288 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Hyung Duk Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul …. Hauptthemen laut MEDLINE: Kidney Transplantation, Basiliximab, Antilymphocyte Serum, Immunosuppressive Agents. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea (NRF).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Induction immunosuppressive therapy for kidney transplant recipients (KTRs) primarily includes interleukin-2 receptor antagonists, such as basiliximab (BXM) or lymphocyte-depleting agents, and anti-thymocyte globulin (ATG). This study aimed to investigate their effects on T cell dynamics during the early post-transplantation period. This prospective observational study included 157 KTRs. Peripheral blood samples were collected from each patient within 5 days before and 4 and 12 weeks after transplantation. Flow cytometric analysis was performed to assess various T cell subsets whose changes were then analyzed. In the ATG group, CD4+ T cell expression decreased significantly compared with that in the BXM group. However, CD4+CD161+ and CD4+CD25+CD127low T cell expression levels increased significantly. In the CD8+ T cell subset, a decrease in CD8+CD28nullCD57+ and CD8+CCR7+ T cell expression was observed in the ATG group. However, among patients diagnosed with biopsy-proven acute rejection, T cell subset expression did not significantly differ relative to non-rejection cases. In conclusion, ATG induction therapy resulted in more pronounced changes in T lymphocyte subsets than BXM induction, with increased CD4+CD161+ and CD4+CD25+CD127low T cells and an early decrease in CD8+CD28nullCD57+ and CD8+CCR7+ T cells, some of which are associated with acute rejection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Kidney TransplantationBasiliximabAntilymphocyte SerumImmunosuppressive AgentsT-Lymphocyte SubsetsHumansMaleFemaleMiddle AgedProspective StudiesAdultGraft RejectionAged

Stichwörter der Autor:innen

T lymphocyte subsetsanti-thymocyte globulinbasiliximabkidney transplantation

Substanzen

BasiliximabAntilymphocyte SerumImmunosuppressive Agents

Autor:innen und Institutionen

  • Division of Nephrology, Department of Internal Medicine, Eunpyeong St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 03312, Republic of Korea.
  • Department of Biomedical Science, Graduate School, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Division of Nephrology, Department of Internal Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Division of Nephrology, Department of Internal Medicine, Incheon St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Incheon 21431, Republic of Korea.
  • Department of Laboratory Medicine, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul 06591, Republic of Korea.
  • Research and Development Institute for In Vitro Diagnostic Medical Devices, The Catholic University of Korea, Seoul 06591, Republic of Korea.

ORCID-Profile: Hyung Duk Kim, Hyunjoo Bae, Hanbi Lee, Chul Woo Yang, Eun-Jee Oh, Byung Ha Chung

Förderung

  • National Research Foundation of Korea (NRF)

Zitieren

APA

Kim, H. D., Bae, H., Yun, S., Lee, H., Eum, S. H., Yang, C. W., Oh, E. J., & Chung, B. H. (2023). Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241814288

Vancouver

Kim HD, Bae H, Yun S, Lee H, Eum SH, Yang CW, et al. Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241814288

BibTeX
@article{Kim2023,
  author = {Kim, Hyung Duk and Bae, Hyunjoo and Yun, Sojeong and Lee, Hanbi and Eum, Sang Hun and Yang, Chul Woo and Oh, Eun-Jee and Chung, Byung Ha},
  title = {Impact of Induction Immunosuppressants on T Lymphocyte Subsets after Kidney Transplantation: A Prospective Observational Study with Focus on Anti-Thymocyte Globulin and Basiliximab Induction Therapies},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241814288}
}
Kostenlos starten →